Abstract
The results of a study on the correction of luteal phase defi ciency (NLF) in women with hypothyroidism using non-hormonal drug complex action Tazalok are presented in the article.The study included 82 women aged 20 to 38 years with regular menstrual cycles. Women were divided into two clinical groups: 12 (14%) patients with ovulatory menstrual cycle, 70 (83%) woman with NLF. All women with NLF and hypothyroidism we prescribe herbal drug Tazalok at a dosage of 30 drops 3 times a day 30 minutes before meals for 12 weeks to restore the ovulation on the background of hypothyroidism correction to the euthyroid state.The effi cacy of therapy with Tazalok was obtained in 97% of cases of use, 3% women with severe and persistent anovulation had additional drug therapy.The study demonstrated that the Tazalok use can effi cient and dynamic improve the quality of women life, and an increased concentration of serumprogesterone during therapy can be recommended this phytogestagen drug as an eff ective for the correction of NLF, including hypothyroidism, as well as relative or absolute giperestrogeniya
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
